HIV molecular immunology database
Found 1 matching record:
| HXB2 Location | Gag(77-85) | Gag Epitope Map
View variants at this location |
||||
|---|---|---|---|---|---|---|
| Epitope |
SLYNTVATL
|
Epitope Alignment | ||||
| Variants |
|
|||||
| Epitope Name | SL9 | |||||
| Species (MHC/HLA) | human(A*02:01) | |||||
Showing 1 of 7 variants.
| Variant ID. | 3557 |
|---|---|
| Epitope Seq. | SLYNTVATL |
| Variant Seq. | SLfNTVATL |
| Mutations | Y/F |
| Epitope Location | Y3F |
| HXB2 Location | Y79F |
| Mutation Type | SSF: subtype-specific susceptible form |
| Epitope Subtype | B |
| Variant Subtype | A |
| Method | CD8 T-cell Elispot - IFNy, Other |
| Note | Clade A variant, SLfNTVATL, was also recognized on CD4+ T cells by ImmTAVs m121 and m134. |
Yang2016 Hongbing Yang, Sandrine Buisson, Giovanna Bossi, Zoë Wallace, Gemma Hancock, Chun So, Rebecca Ashfield, Annelise Vuidepot, Tara Mahon, Peter Molloy, Joanne Oates, Samantha J. Paston, Milos Aleksic, Namir J. Hassan, Bent K. Jakobsen, and Lucy Dorrell. Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-Suppressed Subjects by Engineered Immune-Mobilizing T-Cell Receptors. Mol. Ther., 24(11):1913-1925, Nov 2016. PubMed ID: 27401039. Show all entries for this paper.